📊 INVX Key Takeaways
Is Innovex International, Inc. (INVX) a Good Investment?
Innovex demonstrates revenue momentum with 48% YoY growth and fortress-like balance sheet with $200.7M cash and minimal debt. However, the company is operationally unprofitable with -$21.8M operating income and negative net margins at -7.0%, indicating fundamental profitability challenges despite scale. Growth quality is poor—top-line expansion is not translating to bottom-line profitability, signaling either structural business model issues or unsustainable market dynamics in the cyclical oil & gas equipment sector.
Innovex shows strong balance-sheet quality, excellent free-cash-flow generation, and very strong reported revenue growth, which together point to a fundamentally resilient business. However, profit conversion is harder to assess because gross margin is extremely thin and the reported operating income exceeds gross profit, suggesting unusual items or classification effects that reduce earnings clarity. The company looks financially healthy, but growth quality and margin sustainability need confirmation before a more bullish view is justified.
Why Buy Innovex International, Inc. Stock? INVX Key Strengths
- Strong revenue growth of 48% YoY demonstrates market demand and business expansion
- Exceptional balance sheet with only $18M long-term debt, Debt/Equity of 0.02x, and $200.7B cash providing financial flexibility
- Strong liquidity position with Current Ratio of 5.10x and Quick Ratio of 3.38x ensures operational flexibility
- Very strong liquidity and low leverage, with $203.41M cash, a 4.91x current ratio, and debt/equity of just 0.02x
- Excellent cash generation, with $190.91M operating cash flow and $180.00M free cash flow, supporting an 18.4% FCF margin
- Revenue grew 48.0% year over year while ROA and ROE remain positive, indicating the business is scaling from a position of financial strength
INVX Stock Risks: Innovex International, Inc. Investment Risks
- Operating losses of -$21.8M and net losses of -$16.7M indicate company is unprofitable at scale with negative ROE (-1.6%) and ROA (-1.3%)
- Critically low gross margin of 9.7% and operating margin of -9.1% suggest severe unit economics issues or unsustainable pricing pressure
- Revenue growth is not converting to profitability; deteriorating EPS of -$0.24 (down 56.7% YoY) indicates worsening operational performance despite top-line growth
- Cyclical industry exposure (oil & gas field machinery) combined with structural unprofitability creates elevated downside risk
- Gross margin of 2.4% is extremely low, leaving limited room for execution mistakes or cost inflation
- Reported operating income exceeds gross profit, which may indicate one-time items or accounting classification effects that weaken earnings quality assessment
- Net income was flat year over year while diluted EPS fell 56.7%, suggesting dilution or other per-share pressure despite higher revenue
Key Metrics to Watch
- Path to operating profitability and gross margin improvement trajectory
- Operating cash flow sustainability relative to capital expenditure demands
- Quarterly net income trends and return to positive operating margins
- Gross margin and operating margin normalization over the next few filings
- Diluted share count and the relationship between net income growth and EPS growth
Innovex International, Inc. (INVX) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 3.7% FCF margin may limit capital allocation flexibility. Strong liquidity with a 5.10x current ratio provides a solid financial cushion.
INVX Profit Margin, ROE & Profitability Analysis
INVX vs Industrial Sector: How Innovex International, Inc. Compares
How Innovex International, Inc. compares to Industrial sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Innovex International, Inc. Stock Overvalued? INVX Valuation Analysis 2026
Based on fundamental analysis, Innovex International, Inc. has mixed fundamental signals relative to the Industrial sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Innovex International, Inc. Balance Sheet: INVX Debt, Cash & Liquidity
INVX Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Innovex International, Inc.'s revenue has grown significantly by 161% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.29 reflects profitable operations.
INVX Revenue Growth, EPS Growth & YoY Performance
INVX Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $239.0M | $14.8M | $0.21 |
| Q3 2025 | $151.8M | $39.2M | $0.57 |
| Q2 2025 | $130.3M | $9.5M | $0.22 |
| Q1 2025 | $128.0M | $14.8M | $0.21 |
| Q3 2024 | $139.1M | $15.4M | $0.48 |
| Q3 2022 | $73.2M | $702.0K | $0.02 |
| Q2 2022 | $73.4M | -$5.6M | $-0.16 |
| Q1 2022 | $73.1M | -$8.9M | $-0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Innovex International, Inc. Dividends, Buybacks & Capital Allocation
INVX SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Innovex International, Inc. (CIK: 0001042893)
📋 Recent SEC Filings
❓ Frequently Asked Questions about INVX
What is the AI rating for INVX?
Innovex International, Inc. (INVX) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (HOLD) with 71% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are INVX's key strengths?
Claude: Strong revenue growth of 48% YoY demonstrates market demand and business expansion. Exceptional balance sheet with only $18M long-term debt, Debt/Equity of 0.02x, and $200.7B cash providing financial flexibility. ChatGPT: Very strong liquidity and low leverage, with $203.41M cash, a 4.91x current ratio, and debt/equity of just 0.02x. Excellent cash generation, with $190.91M operating cash flow and $180.00M free cash flow, supporting an 18.4% FCF margin.
What are the risks of investing in INVX?
Claude: Operating losses of -$21.8M and net losses of -$16.7M indicate company is unprofitable at scale with negative ROE (-1.6%) and ROA (-1.3%). Critically low gross margin of 9.7% and operating margin of -9.1% suggest severe unit economics issues or unsustainable pricing pressure. ChatGPT: Gross margin of 2.4% is extremely low, leaving limited room for execution mistakes or cost inflation. Reported operating income exceeds gross profit, which may indicate one-time items or accounting classification effects that weaken earnings quality assessment.
What is INVX's revenue and growth?
Innovex International, Inc. reported revenue of $239.0M.
Does INVX pay dividends?
Innovex International, Inc. does not currently pay dividends.
Where can I find INVX SEC filings?
Official SEC filings for Innovex International, Inc. (CIK: 0001042893) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is INVX's EPS?
Innovex International, Inc. has a diluted EPS of $-0.24.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is INVX a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Innovex International, Inc. has a SELL rating with 71% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is INVX stock overvalued or undervalued?
Valuation metrics for INVX: ROE of -1.6% (sector avg: 15%), net margin of -7.0% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy INVX stock in 2026?
Our dual AI analysis gives Innovex International, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is INVX's free cash flow?
Innovex International, Inc.'s operating cash flow is $19.8M, with capital expenditures of $10.9M. FCF margin is 3.7%.
How does INVX compare to other Industrial stocks?
Vs Industrial sector averages: Net margin -7.0% (avg: 10%), ROE -1.6% (avg: 15%), current ratio 5.10 (avg: 1.8).